<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03265535</url>
  </required_header>
  <id_info>
    <org_study_id>2016P002531</org_study_id>
    <nct_id>NCT03265535</nct_id>
  </id_info>
  <brief_title>Validation of a Single Rest-Stress Imaging Protocol for Myocardial Perfusion Imaging</brief_title>
  <official_title>Validation of a Single Rest-Stress Imaging Protocol for Myocardial Perfusion Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      We propose a single-scan two-injection myocardial perfusion imaging protocol using ammonia.
      Subjects will undergo single-scan two-injection imaging as well as regular stress single-scan
      single-injection protocol and the myocardial blood flow of both techniques will be compared.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Stress MBF</measure>
    <time_frame>Single session (&lt;2 hours)</time_frame>
    <description>Difference in stress myocardial blood flow measured by the single-scan two-injection protocol versus conventional single-scan single-injection stress protocol</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Myocardial Ischemia</condition>
  <arm_group>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <description>Subjects without history of coronary artery disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subjects with coronary artery disease</arm_group_label>
    <description>Subjects with coronary artery disease and abnormal SPECT myocardial perfusion imaging within the last 12 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Single-Scan Two-Injection Protocol</intervention_name>
    <description>Single-Scan Two-Injection Protocol</description>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <arm_group_label>Subjects with coronary artery disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of the Massachusetts General Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Healthy Volunteers:

        Inclusion Criteria:

          -  Subjects must be ≥30 and ≤75 years of age;

          -  Subjects must provide informed consent prior to study procedures;

        Exclusion Criteria:

          -  History of CAD, including:

          -  Prior abnormal myocardial perfusion study

          -  History of MI

          -  History of angina

          -  Coronary artery obstruction &gt;50% on CTA and/or angiography

          -  Left ventricular ejection fraction &lt;50%

          -  Any relative or absolute contraindication to adenosine stress, including:

          -  2nd or 3rd degree heart block

          -  Bradycardia (HR&lt;50 bpm)

          -  Recent acute coronary syndrome (ACS)

          -  Unstable angina

          -  Severe heart failure (left ventricular ejection fraction &lt;15%)

          -  Ventricular arrhythmia

          -  Severe asthma and/or chronic obstructive pulmonary disease (COPD)

          -  Baseline hypotension defined as systolic blood pressure &lt; 90 mmHg

          -  Caffeine intake within 24 hours prior to imaging

          -  Current use of theophylline, dipyridamole, or carbamazepine

          -  Allergy or intolerance to adenosine

          -  Positive serum and/or urine pregnancy test, or lactating, or possibility of pregnancy
             cannot be ruled out prior to dosing;

        Subjects with CAD:

        Inclusion criteria

          -  Subjects must be ≥30 and ≤75 years of age;

          -  Subjects must provide informed consent prior to study procedures;

          -  Abnormal myocardial perfusion study within the past 12 months

        Exclusion criteria

          -  Revascularization (percutaneous coronary intervention and/or coronary artery bypass)
             following last myocardial perfusion study

          -  Acute coronary syndrome within 30 days

          -  Left ventricular ejection fraction &lt;50%

          -  Any relative or absolute contraindication to adenosine stress, including:

          -  2nd or 3rd degree heart block

          -  Bradycardia (HR&lt;50 bpm)

          -  Recent acute coronary syndrome (ACS)

          -  Unstable angina

          -  Severe heart failure (left ventricular ejection fraction &lt;15%)

          -  Ventricular arrhythmia

          -  Severe asthma and/or chronic obstructive pulmonary disease (COPD)

          -  Baseline hypotension defined as systolic blood pressure &lt; 90 mmHg

          -  Caffeine intake within 24 hours prior to imaging

          -  Current use of theophylline, dipyridamole, or carbamazepine

          -  Allergy or intolerance to adenosine

          -  Any clinically significant acute or unstable physical or psychological disease, judged
             by the investigators, to be incompatible with the study;

          -  Radiation exposure exceeds current Radiology Department guidelines (i.e. 50 mSv in the
             prior 12 months);

          -  Female participants only: Positive serum and/or urine pregnancy test, or lactating, or
             possibility of pregnancy cannot be ruled out prior to dosing;

          -  Inability to provide written informed consent;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Julia Scotton, BS</last_name>
    <phone>617-643-1967</phone>
    <email>jscotton@partners.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Scotton, BS</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2017</study_first_submitted>
  <study_first_submitted_qc>August 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2017</study_first_posted>
  <last_update_submitted>September 26, 2017</last_update_submitted>
  <last_update_submitted_qc>September 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Georges El Fakhri</investigator_full_name>
    <investigator_title>Director, Gordon Center for Medical Imaging</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

